For: | Vizirianakis IS. Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned. World J Pharmacol 2014; 3(4): 110-119 [DOI: 10.5497/wjp.v3.i4.110] |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v3/i4/110.htm |
Number | Citing Articles |
1 |
IOANNIS S. VIZIRIANAKIS, GEORGE A. MYSTRIDIS, KONSTANTINOS AVGOUSTAKIS, DIMITRIOS G. FATOUROS, MARIOS SPANAKIS. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review). Oncology Reports 2016; 35(4): 1891 doi: 10.3892/or.2016.4575
|
2 |
Ioannis S. Vizirianakis, Androulla N. Miliotou, George A. Mystridis, Eleftherios G. Andriotis, Ioannis I. Andreadis, Lefkothea C. Papadopoulou, Dimitrios G. Fatouros. Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics. Expert Review of Precision Medicine and Drug Development 2019; 4(3): 139 doi: 10.1080/23808993.2019.1605828
|